Digital Occlusal Wafer Versus Waferless Distal Segment Repositioning for BSSO in Skeletal Mandibular Deformities
Launched by CAIRO UNIVERSITY · Nov 25, 2021
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
The use of waferless orthognathic surgery technique raised the question of efficiency versus the use of occlusal wafers and whether it has a significant measurable effect on the surgical outcome and objectives.
Modification and attempts to refine the treatment protocols through computer assisted design or computer-generated surgical Wafer splints, have greatly revolutionized the incorporation of digital imaging and 3D design in Orthognathic surgery. Combining the knowledge acquired from later studies with the advancement in 3D design software and increased resolution of imaging, waferless ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients in need of bilateral sagittal split osteotomy for mandibular repositioning.
- • All patients are free from any systemic disease that may affect normal bone healing.
- • Sufficient dentition to reproduce the occlusal relationships
- • Patient's consent to participate
- Exclusion Criteria:
- • Patients with any systemic disease that may affect normal healing
- • Intra-bony lesions or infections that may interfere with surgery.
- • Previous orthognathic surgeries.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, El Manial, Egypt
Patients applied
Trial Officials
Mohamed Omara, PhD
Study Chair
Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University
Hesham O Morsi, MDSc
Principal Investigator
Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials